Unlicensed and Off-Label Medicines
At MyHairImplants, our clinicians may sometimes prescribe treatments that are described as “off-label” or “unlicensed.” This page explains what these terms mean and why such treatments may be used as part of your care.
Understanding medicine licensing
In the UK, most medicines receive a marketing authorisation (also known as a product licence) before they are widely supplied. This approval confirms that regulators have reviewed the medicine’s quality, safety and effectiveness for specific conditions, doses and methods of use.
The licence outlines details such as:
the condition the medicine is approved to treat
the recommended dosage
how the medicine should be taken
which groups of patients it is suitable for
When a medicine is used exactly according to these approved conditions, it is known as licensed or “on-label” use.
What is off-label use?
A medicine is considered off-label when it is prescribed in a way that differs from the exact terms of its licence. This may include:
using the medicine to treat a different condition
prescribing a different dose
using a different formulation or method of administration
Even if a medicine is not licensed for a particular use, healthcare professionals may still prescribe it when clinical evidence or established medical practice supports its safety and effectiveness. Off-label prescribing is common across many areas of medicine and is a recognised part of clinical practice.
What does “unlicensed medicine” mean?
An unlicensed medicine is a treatment that does not currently hold a UK product licence.
This may happen for several reasons, for example:
the medicine is still awaiting regulatory approval
the treatment is licensed in another country but not in the UK
the medicine has been specially prepared for a specific patient
the manufacturer has not applied for a licence for that particular product
In some cases, medicines may be produced by a licensed manufacturer when there is no suitable licensed alternative available.
Why these medicines may be prescribed
Healthcare professionals may prescribe off-label or unlicensed treatments when they believe doing so is in the patient’s best medical interests.
This may be considered when:
research or clinical experience suggests the treatment may be beneficial
licensed treatments have not produced the desired results
a different formulation better suits the patient’s needs
there is no licensed treatment available for the condition
Regulatory guidance states that prescribers must be satisfied that there is sufficient evidence or experience supporting the medicine’s safety and effectiveness before recommending it.
How this applies to hair-loss treatments
Hair-loss treatment is one area where medicines are sometimes used outside their original licence conditions.
This does not mean the treatment is unsafe or experimental. In many cases:
the medicine has been used in clinical practice for many years
research supports its use for hair loss
healthcare professionals have significant experience prescribing it
Your clinician will only recommend a treatment after reviewing your consultation and determining whether it is appropriate for you.
Safety and clinical oversight
When prescribing treatments, clinicians at MyHairImplants follow established medical standards.
This includes:
reviewing your consultation and medical history
assessing whether the treatment is suitable for you
prescribing only when the potential benefits outweigh the risks
providing guidance on how to use the medication safely
If you have any questions about your treatment or how it works, our clinical team will be happy to help.